HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Commissioner-apparent Jane Henney, MD, has support from H&BA industry.

This article was originally published in The Rose Sheet

Executive Summary

FDA COMMISSIONER-DESIGNATE HENNEY BEGINS CAPITOL HILL ROUNDS, following the White House announcement of its "intent to nominate" University of New Mexico VP-Health Sciences Jane Henney, MD, as FDA commissioner June 23. While the Senate confirmation process cannot begin until a formal nomination is made, Henney will now be able to meet with Labor & Human Resources Committee members in a semi-official capacity to begin to address questions about her qualifications and plans for the agency.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005554

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel